Global Clinical Trial Imaging Market - Size and Forecast Analysis, 2021-2035

Chapter 1 Clinical Trial Imaging Market Executive Summary

• 1.1 Clinical Trial Imaging Market Research Scope
• 1.2 Clinical Trial Imaging Market Estimates and Forecast (2021-2033)
• 1.2.1 Global Clinical Trial Imaging Market Value and Growth Rate (2021-2033)
• 1.2.2 Global Clinical Trial Imaging Market Price Trend (2021-2033)
• 1.3 Global Clinical Trial Imaging Market Value Comparison, by Modality (2021-2033)
• 1.3.1 PET
• 1.3.2 CT
• 1.3.3 MRI
• 1.3.4 X-Ray
• 1.3.5 Ultrasound
• 1.3.6 Echocardiography
• 1.4 Global Clinical Trial Imaging Market Value Comparison, by Application (2021-2033)
• 1.4.1 Pharmaceutical
• 1.4.2 Biotechnology
• 1.4.3 Medical Devices
• 1.4.4 Others
• 1.5 Global Clinical Trial Imaging Market Value Comparison, by Services (2021-2033)
• 1.5.1 Operational Imaging Services
• 1.5.2 Trial Design Consulting Services
• 1.5.3 Read Analysis Services

Chapter 2 Research Methodology

• 2.1 Introduction
• 2.2 Data Capture Sources
• 2.2.1 Primary Sources
• 2.2.2 Secondary Sources
• 2.3 Market Size Estimation
• 2.4 Market Forecast
• 2.5 Assumptions and Limitations

Chapter 3 Market Dynamics

• 3.1 Market Trends
• 3.2 Opportunities and Drivers
• 3.3 Challenges
• 3.4 Market Restraints
• 3.5 Porter's Five Forces Analysis

Chapter 4 Supply Chain Analysis and Marketing Channels

• 4.1 Clinical Trial Imaging Supply Chain Analysis
• 4.2 Marketing Channels
• 4.3 Clinical Trial Imaging Suppliers List
• 4.4 Clinical Trial Imaging Distributors List
• 4.5 Clinical Trial Imaging Customers

Chapter 5 COVID-19 & Russia–Ukraine War Impact Analysis

• 5.1 COVID-19 Impact Analysis on Clinical Trial Imaging Market
• 5.2 Russia-Ukraine War Impact Analysis on Clinical Trial Imaging Market

Chapter 6 Clinical Trial Imaging Market Estimate and Forecast by Region

• 6.1 Global Clinical Trial Imaging Market Value by Region: 2021 VS 2023 VS 2033
• 6.2 Global Clinical Trial Imaging Market Scenario by Region (2021-2023)
• 6.2.1 Global Clinical Trial Imaging Market Value Share by Region (2021-2023)
• 6.3 Global Clinical Trial Imaging Market Forecast by Region (2024-2033)
• 6.3.1 Global Clinical Trial Imaging Market Value Forecast by Region (2024-2033)
• 6.4 Geographic Market Analysis: Market Facts and Figures
• 6.4.1 North America Clinical Trial Imaging Market Estimates and Projections (2021-2033)
• 6.4.2 Europe Clinical Trial Imaging Market Estimates and Projections (2021-2033)
• 6.4.3 Asia Pacific Clinical Trial Imaging Market Estimates and Projections (2021-2033)
• 6.4.4 Latin America Clinical Trial Imaging Market Estimates and Projections (2021-2033)
• 6.4.5 Middle East & Africa Clinical Trial Imaging Market Estimates and Projections (2021-2033)

Chapter 7 Global Clinical Trial Imaging Competition Landscape by Players

• 7.1 Global Top Clinical Trial Imaging Players by Value (2021-2023)
• 7.2 Clinical Trial Imaging Headquarters and Sales Region by Company
• 7.3 Company Recent Developments, Mergers & Acquisitions, and Expansion Plans

Chapter 8 Global Clinical Trial Imaging Market, by Modality

• 8.1 Global Clinical Trial Imaging Market Value, by Modality (2021-2033)
• 8.1.1 PET
• 8.1.2 CT
• 8.1.3 MRI
• 8.1.4 X-Ray
• 8.1.5 Ultrasound
• 8.1.6 Echocardiography

Chapter 9 Global Clinical Trial Imaging Market, by Application

• 9.1 Global Clinical Trial Imaging Market Value, by Application (2021-2033)
• 9.1.1 Pharmaceutical
• 9.1.2 Biotechnology
• 9.1.3 Medical Devices
• 9.1.4 Others

Chapter 10 Global Clinical Trial Imaging Market, by Services

• 10.1 Global Clinical Trial Imaging Market Value, by Services (2021-2033)
• 10.1.1 Operational Imaging Services
• 10.1.2 Trial Design Consulting Services
• 10.1.3 Read Analysis Services

Chapter 11 North America Clinical Trial Imaging Market

• 11.1 Overview
• 11.2 North America Clinical Trial Imaging Market Value, by Country (2021-2033)
• 11.2.1 U.S.
• 11.2.2 Canada
• 11.2.3 Mexico
• 11.3 North America Clinical Trial Imaging Market Value, by Modality (2021-2033)
• 11.3.1 PET
• 11.3.2 CT
• 11.3.3 MRI
• 11.3.4 X-Ray
• 11.3.5 Ultrasound
• 11.3.6 Echocardiography
• 11.4 North America Clinical Trial Imaging Market Value, by Application (2021-2033)
• 11.4.1 Pharmaceutical
• 11.4.2 Biotechnology
• 11.4.3 Medical Devices
• 11.4.4 Others
• 11.5 North America Clinical Trial Imaging Market Value, by Services (2021-2033)
• 11.5.1 Operational Imaging Services
• 11.5.2 Trial Design Consulting Services
• 11.5.3 Read Analysis Services

Chapter 12 Europe Clinical Trial Imaging Market

• 12.1 Overview
• 12.2 Europe Clinical Trial Imaging Market Value, by Country (2021-2033)
• 12.2.1 UK
• 12.2.2 Germany
• 12.2.3 France
• 12.2.4 Spain
• 12.2.5 Italy
• 12.2.6 Russia
• 12.2.7 Rest of Europe
• 12.3 Europe Clinical Trial Imaging Market Value, by Modality (2021-2033)
• 12.3.1 PET
• 12.3.2 CT
• 12.3.3 MRI
• 12.3.4 X-Ray
• 12.3.5 Ultrasound
• 12.3.6 Echocardiography
• 12.4 Europe Clinical Trial Imaging Market Value, by Application (2021-2033)
• 12.4.1 Pharmaceutical
• 12.4.2 Biotechnology
• 12.4.3 Medical Devices
• 12.4.4 Others
• 12.5 Europe Clinical Trial Imaging Market Value, by Services (2021-2033)
• 12.5.1 Operational Imaging Services
• 12.5.2 Trial Design Consulting Services
• 12.5.3 Read Analysis Services

Chapter 13 Asia Pacific Clinical Trial Imaging Market

• 13.1 Overview
• 13.2 Asia Pacific Clinical Trial Imaging Market Value, by Country (2021-2033)
• 13.2.1 China
• 13.2.2 Japan
• 13.2.3 India
• 13.2.4 South Korea
• 13.2.5 Australia
• 13.2.6 Southeast Asia
• 13.2.7 Rest of Asia Pacific
• 13.3 Asia Pacific Clinical Trial Imaging Market Value, by Modality (2021-2033)
• 13.3.1 PET
• 13.3.2 CT
• 13.3.3 MRI
• 13.3.4 X-Ray
• 13.3.5 Ultrasound
• 13.3.6 Echocardiography
• 13.4 Asia Pacific Clinical Trial Imaging Market Value, by Application (2021-2033)
• 13.4.1 Pharmaceutical
• 13.4.2 Biotechnology
• 13.4.3 Medical Devices
• 13.4.4 Others
• 13.5 Asia Pacific Clinical Trial Imaging Market Value, by Services (2021-2033)
• 13.5.1 Operational Imaging Services
• 13.5.2 Trial Design Consulting Services
• 13.5.3 Read Analysis Services

Chapter 14 Latin America Clinical Trial Imaging Market

• 14.1 Overview
• 14.2 Latin America Clinical Trial Imaging Market Value, by Country (2021-2033)
• 14.2.1 Brazil
• 14.2.2 Argentina
• 14.2.3 Rest of Latin America
• 14.3 Latin America Clinical Trial Imaging Market Value, by Modality (2021-2033)
• 14.3.1 PET
• 14.3.2 CT
• 14.3.3 MRI
• 14.3.4 X-Ray
• 14.3.5 Ultrasound
• 14.3.6 Echocardiography
• 14.4 Latin America Clinical Trial Imaging Market Value, by Application (2021-2033)
• 14.4.1 Pharmaceutical
• 14.4.2 Biotechnology
• 14.4.3 Medical Devices
• 14.4.4 Others
• 14.5 Latin America Clinical Trial Imaging Market Value, by Services (2021-2033)
• 14.5.1 Operational Imaging Services
• 14.5.2 Trial Design Consulting Services
• 14.5.3 Read Analysis Services

Chapter 15 Middle East & Africa Clinical Trial Imaging Market

• 15.1 Overview
• 15.2 Middle East & Africa Clinical Trial Imaging Market Value, by Country (2021-2033)
• 15.2.1 Saudi Arabia
• 15.2.2 UAE
• 15.2.3 South Africa
• 15.2.4 Rest of Middle East & Africa
• 15.3 Middle East & Africa Clinical Trial Imaging Market Value, by Modality (2021-2033)
• 15.3.1 PET
• 15.3.2 CT
• 15.3.3 MRI
• 15.3.4 X-Ray
• 15.3.5 Ultrasound
• 15.3.6 Echocardiography
• 15.4 Middle East & Africa Clinical Trial Imaging Market Value, by Application (2021-2033)
• 15.4.1 Pharmaceutical
• 15.4.2 Biotechnology
• 15.4.3 Medical Devices
• 15.4.4 Others
• 15.5 Middle East & Africa Clinical Trial Imaging Market Value, by Services (2021-2033)
• 15.5.1 Operational Imaging Services
• 15.5.2 Trial Design Consulting Services
• 15.5.3 Read Analysis Services

Chapter 16 Company Profiles and Market Share Analysis: (Business Overview, Market Share Analysis, Products/Services Offered, Recent Developments)

• 16.1 Biotelemetry, Inc.
• 16.2 Cardiovascular Imaging Technologies, LLC
• 16.3 Radiant Sage LLC
• 16.4 Worldcare Clinical, LLC
• 16.5 Intrinsic Imaging LLC
• 16.6 Bioclinica, Inc.
• 16.7 Parexel International Corporation
• 16.8 Icon PLC
• 16.9 Biomedical Systems Corporation
• 16.10 Ixico PLC
• 16.11 Others